MLH1 promoter methylation is a well-known epigenetic alteration in the tumorigenesis of colorectal cancer (CRC) and endometrial cancer (EC), the two most recurrent tumors found in Lynch syndrome (LS) patients. Here, MLH1 is linked to endometrial cancer.